Search Within

Yelena Shames

Formats
  1. Meeting Abstract (9)
  2. Journal Article (3)
Groups
  1. Advanced Practice Providers (12)
  2. Nursing (12)
  3. Department of Medicine (7)
  4. Melanoma and Immunotherapeutics Service (7)
  5. Solid Tumor Oncology Division (7)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)

More Groups

People
  1. Margaret Callahan (6)
  2. Nana Prempeh-Keteku (5)
  3. Aya Haggiagi (4)
  4. Bianca Santomasso (4)
  5. Jenessa Holder (4)
  6. Rachna Malani (4)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2018 (2)
  4. 2017 (5)
  5. 2016 (3)
Publications
  1. Journal of Clinical Oncology (4)
  2. Oncology Nursing Forum (2)
  3. Asia-Pacific Journal of Oncology Nursing (1)
  4. Clinical Journal of Oncology Nursing (1)
  5. Journal for ImmunoTherapy of Cancer (1)
  6. Journal of the Advanced Practitioner in Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. Oncology Nursing Society (ONS) (3)
  3. Biomed Central Ltd (1)
  4. Harborside Press (1)
  5. Lippincott Williams & Wilkins (1)
  6. Medknow Publications (1)

More Publishers

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • To treat or not to treat? Evaluating abnormal laboratory values in patients receiving immune checkpoint inhibitors
    Meeting Abstract

    Shames, Y.; Errante, M.; Prempeh -Kete Ku, N.
    Oncology Nursing Forum (2023)

    Fulltext@MSK | Save
  • Myasthenia gravis: A rare neurologic complication of immune checkpoint inhibitor therapy
    Journal Article

    Shames, Y.; Errante, M.; Prempeh Keteku, N.
    Journal of the Advanced Practitioner in Oncology (2022)

    Fulltext@MSK | Save
  • Neurologic immune related adverse events (irAEs) in patients treated with immune checkpoint blockade
    Meeting Abstract

    Santomasso, B.; Haggiagi, A.; Malani, R.; Maher, C. A.; Holder, J. N.; Shames, Y.; Wilcox, J.; Flynn, J.; Briggs, S.; Panageas, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: A single institution retrospective analysis
    Meeting Abstract

    Malani, R.; Haggiagi, A.; Holder, J.; Shames, Y.; Briggs, S.; Callahan, M.; Santomasso, B.
    Neurology (2018)

    Fulltext@MSK | Save
  • Neurotoxicity in patients with metastatic solid tumors treated with immune checkpoint inhibitors: A single institution retrospective analysis
    Meeting Abstract

    Santomasso, B.; Malani, R.; Haggiagi, A.; Holder, J.; Shames, Y.; Briggs, S.; Callahan, M.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • The development of neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: A single institution retrospective analysis
    Meeting Abstract

    Malani, R.; Haggiagi, A.; Holder, J.; Shames, Y.; Briggs, S.; Santomasso, B.; Callahan, M.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Checkpoint inhibitors: Common immune-related adverse events and their management
    Journal Article

    Gordon, R.; Kasler, M. K.; Stasi, K.; Shames, Y.; Errante, M.; Ciccolini, K.; Lucas, A. S.; Raasch, P.; Fischer-Cartlidge, E.
    Clinical Journal of Oncology Nursing (2017)

    Fulltext@MSK | Save
  • Management of treatment-related adverse events associated with nivolumab and ipilimumab combination therapy in patients with metastatic melanoma, NSCLC, or RCC
    Meeting Abstract

    Kannan, R.; Mitchell, T.; Sherry, V.; Pons, A.; Kreamer, K.; Shames, Y.
    Oncology Nursing Forum (2017)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitors: An innovation in immunotherapy for the treatment and management of patients with cancer
    Journal Article

    Dine, J.; Gordon, R.; Shames, Y.; Kasler, M. K.; Barton-Burke, M.
    Asia-Pacific Journal of Oncology Nursing (2017)

    Fulltext@MSK | Save
  • Efficacy of nivolumab and ipilimumab (Nivo + Ipi) combination in melanoma patients (pts) treated at a single institution on an expanded-access program (EAP)
    Meeting Abstract

    Shoushtari, A. N.; Navid-Azarbaijani, P.; Friedman, C. F.; Panageas, K.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Campbell, S. C.; Shames, Y.; Prempeh-Keteku, N. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save